Watch to learn the tools that can support more accurate immune profiling and biomarker analysis in NHP-based preclinical research.

Non-human primate (NHP) models are essential for preclinical research due to their close physiological similarity to humans, particularly in immunology and therapeutic development. However, the limited availability of reliable reagents optimized for NHP samples remains a major challenge for many researchers.

This webinar highlights current reagent gaps in NHP preclinical studies and introduces innovative solutions designed to address them. We present ABflo® rabbit monoclonal antibodies developed for NHP flow cytometry, ABplex® Cytometric Bead Array (CBA) kits for sensitive multiplex cytokine detection, and validated antibodies for IHC and multiplex IHC (mIHC) to enable precise biomarker assessment in NHP tissue biopsies.

Key Topics Include:

  • Importance of NHP models in preclinical studies
  • Current reagent gaps in preclinical studies of NHP
  • Unique ABflo® rabbit mAbs developed for NHP flow cytometry
  • High performance ABplex® Cytometric Bead Array (CBA) kits for accurate evaluation of NHP cytokines
  • Precise assessment of Biomarkers in NHP biopsy using IHC and mIHC

Presenters

Hai Wu, ;PhD

Hai Wu, PhD

CTO, VP
Immunology BU
ABclonal Technology

Hai Wu, PhD, is Vice President and Chief Technology Officer of the Immunology Division at ABclonal Technology, where he leads the strategic development of rabbit monoclonal antibodies. He spearheaded the transition of ABclonal’s portfolio from traditional polyclonal antibodies to recombinant rabbit monoclonal antibodies and established an R&D and management framework based on the principle that “Quality by Design,” strengthening capabilities across the full recombinant antibody development workflow.
Watch Webinar

Production Partner

ABclonal Technology

ABclonal Technology is a reagents manufacturer supporting cutting-edge research with high-quality antibodies, molecular enzymes, and more. Our monoclonal antibodies are developed using SMab®, the first antibody discovery platform using single primary B cell ex vivo expansion.

VIEW PROFILE
ABclonal Technology

Additional Content From Scientist.com

Related Content